These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 24823966)
1. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390 [TBL] [Abstract][Full Text] [Related]
3. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597 [TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma. Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038 [TBL] [Abstract][Full Text] [Related]
5. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival. Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731 [TBL] [Abstract][Full Text] [Related]
7. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma. Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425 [TBL] [Abstract][Full Text] [Related]
10. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system. Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492 [TBL] [Abstract][Full Text] [Related]
11. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma. Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997 [TBL] [Abstract][Full Text] [Related]
12. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases. Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484 [TBL] [Abstract][Full Text] [Related]
13. Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma. Harimoto N; Yoshizumi T; Shimagaki T; Nagatsu A; Motomura T; Harada N; Okabe H; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Maehara Y Anticancer Res; 2016 Oct; 36(10):5537-5542. PubMed ID: 27798927 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection. Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy. Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection. Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774 [TBL] [Abstract][Full Text] [Related]
17. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Minagawa M; Makuuchi M; Takayama T; Kokudo N Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733 [TBL] [Abstract][Full Text] [Related]
18. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection. Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411 [TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906 [TBL] [Abstract][Full Text] [Related]
20. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. He CB; Lin XJ PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]